Image via Motley Fool
Last updated
Boston Scientific: Ma Activity
Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Source: Motley Fool
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
Market context: Against a Talent Market Index of 105.8 (Hot) (down 2.4 month-on-month), Americas is at rising (+2.4pts) on signal share.
Boston Scientific: 1 signal in the last 90 days — in line with the MedTech median of 1 across 20 tracked companies.
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed acquisition of SPR Therapeutics for $650M cash. SPR specializes in FDA-cleared short-term peripheral nerve stimulation (PNS) therapy for chronic and acute pain. Deal adds SPRINT PNS System to Medtronic's neuromodulation portfolio.
Ma Activity · Americas
Analog Devices →Analog Devices completed acquisition of Empower Semiconductor to strengthen its position as a power partner across the AI ecosystem
Ma Activity · Americas
McKesson →McKesson planning medical-surgical spinoff and share buyback program, indicating major portfolio restructuring
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Ma Activity · Americas
Abbott →Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Intelligence powered by Autonodal ↗